Inactive Instrument

Insiders Bone Therapeutics SA Euronext Bruxelles

Equities

End-of-day quote Euronext Bruxelles Other stock markets
-	-

04-11	Biosenic: launch of a debt restructuring plan	CF
03-12	Biosenic S.A. Releases Details of Optimized Administration Approach Ahead of Planned Phase 3 Trial of OATO for Chronic Graft-Versus-Host Disease	CI

BioSenic Names Chief Scientific Officer as COO	01-10	MT
Biosenic S.A. and Its Subsidiary Medsenic SAS Announces the Promotion of Carole Nicco to Chief Operating Officer	01-10	CI
Belgium's BioSenic Appoints New Chief Medical Officer	23-04-03	MT
BioSenic S.A. Appoints Lieven Huysse as Chief Medical Officer, Effective 17 April 2023	23-04-03	CI
BioSenic S.A. Appoints Yves Sagot as Independent Director	23-01-27	CI
BioSenic Names New Chief Scientific Officer	23-01-18	MT
BioSenic Appoints Dr. Carole Nicco as Chief Scientific Officer	23-01-18	CI
BioSenic Names Interim Chief Medical Officer	22-12-02	MT
BioSenic S.A. Appoints Michel Wurm as Interim Chief Medical Officer	22-12-02	CI
Bone Therapeutics To Change Name To BioSenic Following Medsenic Deal	22-10-25	MT
Francois Rieger Joins as CEO of BioSenic SA	22-10-25	CI
BioSenic Announces Management Changes	22-10-25	CI
Bone Therapeutics SA has Changed its Name to BioSenic SA	22-10-25	CI
Bone Therapeutics CEO, Other Executives to Leave Amid Revised Strategy; Shares Down 9%	22-03-29	MT
Bone Therapeutics Appoints Scientific Advisory Board for iMSC Cell and Gene Therapy Platform Development	21-10-12	CI
Hyloris Pharmaceuticals : Appoints New CFO From Bone Therapeutics	21-09-23	MT
Bone Therapeutics : Hires Interim CFO	21-09-21	MT
Bone Therapeutics SA Announces Executive Changes	21-09-21	CI
Bone Therapeutics Appoints Anne Leselbaum, MD as Chief Medical Officer, Effective 23 August 2021	21-07-12	CI
Bone Therapeutics : Appoints New Chief Scientific Officer	21-03-30	MT

No results for this search